Details of the Drug

General Information of Drug (ID: DMD6H8B)

Drug Name
GMZ-2
Synonyms Adjuvanted PfGLURP + PfMSP3 vaccine (malaria), AMANET; GLURP-MSP3 bivalent vaccine (malaria), EMVI; Malaria vaccine (PfGLURP + PfMSP3 + aluminium hydroxide adjuvant), EMVI
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D0O1WR

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cell mediated immunity response (CMIR) TT3J5ZI NOUNIPROTAC Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00424944) Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine. U.S. National Institutes of Health.
2 Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malar J. 2011; 10: 359.